Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Province Kuahai Biochemical Pharmaceutical Manufacturing Company is a pharmaceutical enterprise based in Changchun, China, specializing in the production of biochemical drugs. The company is a significant manufacturer of neurological treatments, most notably Compound Ganglioside Injection and Cerebroprotein Hydrolysate Injection. Its operations focus on the research, development, and large-scale manufacturing of therapies for cerebrovascular diseases and central nervous system injuries. Kuahai Pharmaceutical maintains GMP-certified facilities and primarily serves the Chinese domestic hospital market with its portfolio of injectable biochemical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Province Kuahai Biochemical Pharmaceutical Manufacturing Company.